Blaze Bioscience Raises $5M in Series A for Tumor Paint
By Marie Powers
Wednesday, August 8, 2012
Less than two years after its founding and 10 months after licensing its technology from Seattle's Fred Hutchinson Cancer Research Center, privately held Blaze Bioscience Inc. raised $5 million in a Series A financing.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.